pharmaphorum October 13, 2020
Ayming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably promising” despite strong headwinds caused by COVID-19.
The report reveals that R&D departments are being empowered by the creation of ‘innovation ecosystems’, new funding methods, and the deployment of technology.
Ayming surveyed a combination of 330 business executives and R&D managers from 13 countries across North America and Europe. The report covers three sections: The Innovation Landscape, Financing Innovation and Sustainable Innovation.
The report’s authors say that R&D teams remain resolute in the face of several key obstacles.
“Not only has COVID-19 caused expectations for budget increases to decline 12%, but complexity is making it increasingly difficult to innovate successfully, international competition...